TheEdgeResearch
Home / Stocks / NPRRF

Nipro Corporation (NPRRF)

OTC Healthcare Medical - Instruments & Supplies
$9.96 ▲ +0.00%
Market Cap
$1.62B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Beta
-0.59
52-Wk Range
8.23-9.96
CEO
Yoshihiko Sano
Country
JP
Currency
USD

Nipro Corporation operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Osaka, JP. The stock last traded at $9.96, up 0.00% on the session, giving a market capitalisation of $1.62B. On trailing twelve-month figures it carries a trailing P/E of 19.45, a net margin of 2.0%. Its beta of -0.59 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
19.45
Price / Sales
0.40
Price / Book
0.96
EV / EBITDA
7.80
Gross margin
31.5%
Operating margin
5.7%
Net margin
2.0%
Return on equity
Debt / equity
2.33
Current ratio
1.39
Dividend yield
1.8%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
36,259
IPO date
2018-09-03
Headquarters
Osaka, JP
About Nipro Corporation

Nipro Corporation, along with its various subsidiaries, operates as a diversified global enterprise primarily focusing on three key sectors: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device division is responsible for the development, production, and distribution of essential healthcare equipment. This includes products for injection-infusion therapies, dialysis treatments, and solutions for diabetes and cell culture applications, alongside artificial organ-related merchandise. Within the Pharmaceutical segment, Nipro offers a range of innovative combination products, such as dual chamber bags, pre-filled syringes, and convenient half-type kits. Furthermore, it provides comprehensive contract manufacturing services for orally administered, injectable, and topical drugs, complemented by robust logistic and distribution capabilities. The Pharma Packaging division specializes in delivering a complete portfolio of pharmaceutical containers. This encompasses a wide variety of glass products, including vials, ampoules, syringes, and cartridges, alongside glass tubes and glass bulbs designed for vacuum flasks, as well as critical components like rubber plugs. Beyond these core areas, Nipro also manufactures thermostable enzymes vital for clinical chemistry applications through its 'Other business' unit. Additionally, the corporation provides business management services. Established in Osaka, Japan, in 1947, Nipro Corporation maintains a significant international presence, serving markets across Japan, the Americas, Europe, and other parts of Asia.

Comparable companies

Nipro Corporation is most often compared with the following Healthcare names:

BIESFBITGFCMPUYCMPVFDGWPFDWRKFKARBFKSRBFMDRSFMITPF
More research on NPRRF
NPRRF technical analysis NPRRF TheEdge Score Compare against peers
Open full interactive analysis & DCF →